Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients

BACKGROUND: Heparin administration in COVID-19 patients is recommended by expert consensus, although evidence about dosage, duration and efficacy are limited. We aim to investigate the association between different dosages of low molecular weight heparin (LMWH) and mortality among COVID-19 hospitali...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Paolisso, Pasquale, Bergamaschi, Luca, D’Angelo, Emanuela Concetta, Donati, Francesco, Giannella, Maddalena, Tedeschi, Sara, Pascale, Renato, Bartoletti, Michele, Tesini, Giulia, Biffi, Mauro, Cosmi, Benilde, Pizzi, Carmine, Viale, Pierluigi, Galié, Nazzareno
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7424043/
https://ncbi.nlm.nih.gov/pubmed/32848743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01124
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados